Ann Leen, PhD, from Baylor College of Medicine, Houston, TX, US, provides an overview of the ‘off the shelf’ use of virus-specific T cell therapy. At the moment, the therapy targets 5 viruses but the aim is to include more viruses over time.
Recorded at the 2016 Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT) in Valencia, Spain.
Advertisement Single Below Content
Advertisement Single Below Content
Advertisement Single Below Content